TAP Block With Two Different Doses of Levobupivacaine
This trial is active, not recruiting.
|Start date||July 2015|
|End date||January 2016|
|Trial size||50 participants|
|Trial identifier||NCT02567487, 931893045140401|
The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery.
The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.
|Endpoint classification||safety/efficacy study|
|Intervention model||parallel assignment|
|Masking||double blind (investigator, outcomes assessor)|
|Primary purpose||supportive care|
postoperative VAS score <4 at postoperative 24 hours
time frame: Postoperative first 24 hours
Male or female participants from 2 years up to 12 years old.
Inclusion Criteria: - Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and iliohypogastric block) and general anesthesia - Aged between 2 and 12 Exclusion Criteria: - Patients with coagulation dysfunction - Patients with chronic pain - Patients having infection at the site of intervention - Patients with a history of allergy - Patients having chronic diseases (hepatic dysfunction, renal failure)
|Official title||Comparison of TAP Block With Two Different Doses of Levobupivacaine for Postoperative Pain Management in Pediatric Patients|
|Description||Fifty children undergoing TAP block were randomly divided into two groups as levobupivacaine 0.25% 0.5 ml/kg and levobupivacaine 0.25% 0.25 ml/kg. Postoperative pain was evaluated with observational pain scale and modified pediatric objective pain scale.|
Call for more information